Liver disease in transfusion dependent thalassaemia major
Open Access
- 1 May 2002
- journal article
- acute paediatrics
- Published by BMJ in Archives of Disease in Childhood
- Vol. 86 (5) , 344-347
- https://doi.org/10.1136/adc.86.5.344
Abstract
Aims: To study the prevalence and severity of liver diseases of transfusion dependent thalassaemia major patients, and correlate the histological and biochemical changes of iron overload in liver with the peripheral blood markers. Method: Liver biopsy was performed to assess the histological changes and liver iron content (LIC). Results: One hundred patients were evaluated (median age 11.7 years, range 1.5–27). A total of 81 liver biopsies were performed in 73 patients; 43 samples were analysed for LIC. Grade 3–4 haemosiderosis and hepatic fibrosis was found in 44% and 30% of patients respectively; both were significantly associated with higher serum ferritin, liver enzymes, and LIC. Very high LIC (>15 mg/g dry weight) was present in 16.3% of patients. Conclusion: Severe haemosiderosis and hepatic fibrosis were common in patients with thalassaemia major despite the use of chelation therapy. Liver biopsy provided information on fibrosis and LIC which could not be accurately predicted from peripheral blood markers.Keywords
This publication has 20 references indexed in Scilit:
- Needle liver biopsy in thalassaemia: analyses of diagnostic accuracy and safety in 1184 consecutive biopsiesBritish Journal of Haematology, 1995
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994
- Marrow Transplantation in Patients with Thalassemia Responsive to Iron Chelation TherapyNew England Journal of Medicine, 1993
- Growth Failure and Bony Changes Induced by DeferoxamineJournal of Pediatric Hematology/Oncology, 1992
- SURVIVAL AND CAUSES OF DEATH IN THALASSAEMIA MAJORPublished by Elsevier ,1989
- Iron state and hepatic disease in patients with thalassaemia major, treated with long term subcutaneous desferrioxamine.Journal of Clinical Pathology, 1987
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- Evaluation of a prenatal screening procedure for β-thalassaemia carriers in a chinese populationbased on the mean corpuscular volume (MCV)Prenatal Diagnosis, 1985
- Cirrhosis associated with multiple transfusions in thalassaemia.Archives of Disease in Childhood, 1984
- Hereditary HemochromatosisNew England Journal of Medicine, 1979